Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Catherine Gloss"'
Publikováno v:
The American Journal of Dermatopathology. 45:64-68
Ponatinib is a third-generation tyrosine kinase inhibitor used to treat chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia. Cutaneous toxicities are a commonly reported side effect of ponatinib treatment with "rash" being
Autor:
Naveen Balasundaram, Lucy Sheahan, Catherine Gloss, Sadhvika Ramji, Jonathan Bath, Todd R. Vogel
Publikováno v:
Journal of Vascular Surgery. 76:e62-e63